scholarly journals 9. Case studies of vector-borne diseases in livestock: bluetongue virus

2018 ◽  
pp. 221-271
Author(s):  
Miguel Á. Miranda
Keyword(s):  
Case Studies ◽  
Bluetongue Virus ◽  
Vector Borne Diseases ◽  
Vector Borne

scholarly journals Mapping the basic reproduction number (R0) for vector-borne diseases: A case study on bluetongue virus

Epidemics ◽  
2009 ◽  
Vol 1 (3) ◽  
pp. 153-161 ◽  
Author(s):  
N.A. Hartemink ◽  
B.V. Purse ◽  
R. Meiswinkel ◽  
H.E. Brown ◽  
A. de Koeijer ◽  
...  
Keyword(s):  
Basic Reproduction Number ◽  
Bluetongue Virus ◽  
Reproduction Number ◽  
Vector Borne Diseases ◽  
Vector Borne ◽  
The Basic Reproduction Number

scholarly journals Purification, Stability, and Immunogenicity Analyses of Five Bluetongue Virus Proteins for Use in Development of a Subunit Vaccine That Allows Differentiation of Infected from Vaccinated Animals

2014 ◽  
Vol 21 (3) ◽  
pp. 443-452 ◽  
Author(s):  
Jenna Anderson ◽  
Emmanuel Bréard ◽  
Karin Lövgren Bengtsson ◽  
Kjell-Olov Grönvik ◽  
Stéphan Zientara ◽  
...  
Keyword(s):  
Bluetongue Virus ◽  
Subunit Vaccine ◽  
Clinical Signs ◽  
Igg Antibody ◽  
Content Type ◽  
Vector Borne Diseases ◽  
Antibody Titers ◽  
A Subunit ◽  
Bluetongue Disease ◽  
Vector Borne

ABSTRACTBluetongue virus (BTV) causes bluetongue disease, a vector-borne disease of ruminants. The recent northerly spread of BTV serotype 8 in Europe resulted in outbreaks characterized by clinical signs in cattle, including unusual teratogenic effects. Vaccination has been shown to be crucial for controlling the spread of vector-borne diseases such as BTV. With the aim of developing a novel subunit vaccine targeting BTV-8 that allows differentiation of infected from vaccinated animals, five His-tagged recombinant proteins, VP2 and VP5 of BTV-8 and NS1, NS2, and NS3 of BTV-2, were expressed in baculovirus orEscherichia coliexpression systems for further study. Optimized purification protocols were determined for VP2, NS1, NS2, and NS3, which remained stable for detection for at least 560 to 610 days of storage at +4°C or −80°C, and Western blotting using sera from vaccinated or experimentally infected cattle indicated that VP2 and NS2 were recognized by BTV-specific antibodies. To characterize murine immune responses to the four proteins, mice were subcutaneously immunized twice at a 4-week interval with one of three protein combinations plus immunostimulating complex ISCOM-Matrix adjuvant or with ISCOM-Matrix alone (n= 6 per group). Significantly higher serum IgG antibody titers specific for VP2 and NS2 were detected in immunized mice than were detected in controls. VP2, NS1, and NS2 but not NS3 induced specific lymphocyte proliferative responses upon restimulation of spleen cells from immunized mice. The data suggest that these recombinant purified proteins, VP2, NS1, and NS2, could be an important part of a novel vaccine design against BTV-8.

scholarly journals Emerging vector-borne diseases in dromedaries in Tunisia: West Nile, bluetongue, epizootic haemorrhagic disease and Rift Valley fever

2017 ◽  
Vol 84 (1) ◽  
Author(s):  
Thameur B. Hassine ◽  
Jihane Amdouni ◽  
Federica Monaco ◽  
Giovanni Savini ◽  
Soufien Sghaier ◽  
...  
Keyword(s):  
Rift Valley ◽  
Bluetongue Virus ◽  
Rift Valley Fever ◽  
Rift Valley Fever Virus ◽  
West Nile ◽  
Valley Fever ◽  
Vector Borne Diseases ◽  
Serotype 1 ◽  
Vector Borne ◽  
Haemorrhagic Disease

A total of 118 sera were collected during 2016 from two groups of dromedaries from Kebili and Medenine governorates in the south of Tunisia. The aim of this study was to provide the first serological investigation of four emerging vector-borne diseases in two groups of dromedaries in Tunisia. Sera were tested by ELISA and serum neutralisation test to identify West Nile virus (WNV), bluetongue virus (BTV), epizootic haemorrhagic disease virus (EHDV) and Rift Valley fever virus (RVFV). In the first group, the seroprevalence for BTV was 4.6%, while in the second group, it was 25.8% for WNV and 9.7% for BTV. Only serotype 1 was detected for BTV in the two groups. No evidence for circulation of RVF and EHD viruses was revealed. Results indicated that dromedaries can be infected with BTV and WNV, suggesting that this species might play a significant role in the epizootiology of these viral diseases in Tunisia and neighbouring countries.

scholarly journals Bluetongue virus spread in Europe is a consequence of climatic, landscape and vertebrate host factors as revealed by phylogeographic inference

2017 ◽  
Vol 284 (1864) ◽  
pp. 20170919 ◽  
Author(s):  
Maude Jacquot ◽  
Kyriaki Nomikou ◽  
Massimo Palmarini ◽  
Peter Mertens ◽  
Roman Biek
Keyword(s):  
Bluetongue Virus ◽  
Linear Models ◽  
Control Strategies ◽  
Ecological Factors ◽  
Environmental Drivers ◽  
Related Factors ◽  
Continuous Space ◽  
Vector Borne Diseases ◽  
Viral Spread ◽  
Vector Borne

Spatio-temporal patterns of the spread of infectious diseases are commonly driven by environmental and ecological factors. This is particularly true for vector-borne diseases because vector populations can be strongly affected by host distribution as well as by climatic and landscape variables. Here, we aim to identify environmental drivers for bluetongue virus (BTV), the causative agent of a major vector-borne disease of ruminants that has emerged multiple times in Europe in recent decades. In order to determine the importance of climatic, landscape and host-related factors affecting BTV diffusion across Europe, we fitted different phylogeographic models to a dataset of 113 time-stamped and geo-referenced BTV genomes, representing multiple strains and serotypes. Diffusion models using continuous space revealed that terrestrial habitat below 300 m altitude, wind direction and higher livestock densities were associated with faster BTV movement. Results of discrete phylogeographic analysis involving generalized linear models broadly supported these findings, but varied considerably with the level of spatial partitioning. Contrary to common perception, we found no evidence for average temperature having a positive effect on BTV diffusion, though both methodological and biological reasons could be responsible for this result. Our study provides important insights into the drivers of BTV transmission at the landscape scale that could inform predictive models of viral spread and have implications for designing control strategies.

The Spread of Mosquito Borne Disease – Is Climate Change Beginning to Bite?

2019 ◽  
Vol 30 (5) ◽  
pp. 192-194
Author(s):  
John (Luke) Lucas
Keyword(s):  
Climate Change ◽  
Vector Borne Diseases ◽  
Vector Borne

The author considers the threat to vector-borne diseases in the light of climate change.

The Scientific Basis for the Prevention of Zooanthroponoze Vector-Borne Diseases Spread by Parasitic Arthropods of the Center of the East European Plain

2020 ◽  
Vol 14 (1) ◽  
pp. 81-88
Author(s):  
Fedor I. Vasilevich ◽  
Anna M. Nikanorova
Keyword(s):  
Mathematical Models ◽  
Culex Pipiens ◽  
Preventive Measures ◽  
Mosquito Species ◽  
Natural Habitat ◽  
Piperonyl Butoxide ◽  
East European Plain ◽  
Vector Borne Diseases ◽  
Vector Borne ◽  
Kaluga Region

The purpose of the research is development of preventive measures against zooanthroponoze vector-borne diseases spread by parasitic arthropods in the Kaluga Region. Materials and methods. The subject of the research was Ixodidae, mosquitoes, and small mammals inhabiting the Kaluga Region. The census of parasitic arthropods was carried out on the territory of all districts of the Kaluga Region and the city of Kaluga. Open natural habitat and human settlements were investigated. Weather conditions from 2013 to 2018 were also taken into account. For the purposes of the study, we used standard methods for capturing and counting arthropods and mouse-like rodents. In order to obtain mathematical models of small mammal populations, a full factorial experiment was conducted using the collected statistical data. In-process testing of the drug based on s-fenvalerate and piperonyl butoxide were carried out under the conditions of the agricultural collective farm “Niva” of the Kozelsky District, the Kaluga Region, and LLC “Angus Center of Genetics” of the Babyninsky District, the Kaluga Region. Results and discussion. In the Kaluga Region, two species of ixodic ticks are found, namely, Ixodes ricinus and Dermacentor reticulatus, which have two activity peaks. Mosquito may have 3-4 generations in a year in the Kaluga region. The most common mosquito species in the Kaluga Region are Aedes communis, Ae. (Och.) togoi and Ae. (Och.) diantaeus, Culex pipiens Culex Linnaeus, 1758 (Diptera, Culicidae) (Culex pipiens): Cx. pipiens f. pipiens L. (non-autogenic form) and Cx. p. f. molestus Fors. (autogenic form), which interbreed, and reproductively isolated in the Region. The developed mathematical models make it possible to quantify the risks of outbreaks of zooanthroponoze vector-borne diseases without the cost of field research, and allow for rational, timely and effective preventive measures. Medications based on s-fenvalerate and piperonyl butoxide and based on cyfluthrin showed high insecto-acaricidal efficacy and safety.

Current Challenges in the Development of Vaccines and Drugs Against Emerging Vector-borne Diseases

2019 ◽  
Vol 26 (16) ◽  
pp. 2974-2986 ◽  
Author(s):  
Kwang-sun Kim
Keyword(s):  
New Host ◽  
In Vivo Models ◽  
Vector Borne Diseases ◽  
Novel Drugs ◽  
Huge Impact ◽  
Tick Borne Disease ◽  
Vector Borne ◽  
Living Organisms

Vectors are living organisms that transmit infectious diseases from an infected animal to humans or another animal. Biological vectors such as mosquitoes, ticks, and sand flies carry pathogens that multiply within their bodies prior to delivery to a new host. The increased prevalence of Vector-Borne Diseases (VBDs) such as Aedes-borne dengue, Chikungunya (CHIKV), Zika (ZIKV), malaria, Tick-Borne Disease (TBD), and scrub typhus has a huge impact on the health of both humans and livestock worldwide. In particular, zoonotic diseases transmitted by mosquitoes and ticks place a considerable burden on public health. Vaccines, drugs, and vector control methods have been developed to prevent and treat VBDs and have prevented millions of deaths. However, development of such strategies is falling behind the rapid emergence of VBDs. Therefore, a comprehensive approach to fighting VBDs must be considered immediately. In this review, I focus on the challenges posed by emerging outbreaks of VBDs and discuss available drugs and vaccines designed to overcome this burden. Research into promising drugs needs to be upgraded and fast-tracked, and novel drugs or vaccines being tested in in vitro and in vivo models need to be moved into human clinical trials. Active preventive tactics, as well as new and upgraded diagnostics, surveillance, treatments, and vaccination strategies, need to be monitored constantly if we are to manage VBDs of medical importance.

Sign in / Sign up

Export Citation Format

Share Document